EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Diacylglycerol Kinase Eta as a Novel Target in NRAS Mutant Melanoma

Haley P Wilson, Casey D Stefanski, Signe Caksa, Glenn L Mersky, Scott D Varney, Jelan I Haj, Dan A Erkes, Timothy J Purwin, Vivian Chua, Andrew E Aplin iD

Pigment Cell & Melanoma Research · 2026-05 · 39 (3)

DOI: 10.1111/pcmr.70090 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pigment Cell & Melanoma Research, online erschienen am 21.05.2026. Verfasst von Haley P Wilson und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Physiology, and Cancer Biology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Melanoma, Diacylglycerol Kinase, GTP Phosphohydrolases, Membrane Proteins. Die Arbeit nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIGMS NIH HHS, Dr. Miriam and Sheldon G. Adelson Medical Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

NRAS mutations occur in 10%–30% of cutaneous melanomas and are associated with high tumor mutational burden. Mutant NRAS signaling drives aberrant cell growth and proliferation, in part, through activation of the RAF–MEK‐ERK1/2 kinase pathway; however, targeted therapies to this pathway have limited effectiveness in patients with NRAS mutant melanoma. The role of other targetable signaling pathways in NRAS mutant melanoma is poorly characterized. Here, we demonstrated that one isoform of diacylglycerol kinase, diacylglycerol kinase eta (DGKη), a lipid signaling regulator, was highly expressed in NRAS mutant melanoma patient samples. Knockdown of DGKH in NRAS mutant melanoma cell lines resulted in significant growth inhibition in vitro. Transcriptomic data indicated downregulation of the estrogen response late signature, including decreased CCND1 (cyclin D1) expression following DGKH knockdown. Cell growth inhibition and decreased cyclin D1 expression correlated to an inhibition of cell cycle after DGKH knockdown. These data suggest that DGKη mediates cell cycle progression in NRAS mutant melanoma cells and represents a potential therapeutic target for these patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaDiacylglycerol KinaseGTP PhosphohydrolasesMembrane ProteinsMutationMolecular Targeted TherapyHumansCell ProliferationCell Line, TumorGene Expression Regulation, NeoplasticCyclin D1Gene Knockdown TechniquesCell Cycle

Stichwörter der Autor:innen

NRASdiacylglycerol kinasemelanomaproliferationresistancetargettargeted therapy

Substanzen

Diacylglycerol KinaseGTP PhosphohydrolasesNRAS protein, humanMembrane ProteinsCyclin D1

Autor:innen und Institutionen

  • Department of Pharmacology, Physiology, and Cancer Biology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
  • Sidney Kimmel Comprehensive Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
  • School of Medical and Health Sciences, Edith Cowan University, Perth, Western Australia, Australia.
  • Centre for Precision Health, Edith Cowan University, Perth, Western Australia, Australia.

ORCID-Profile: Andrew E Aplin

Förderung

  • NCI NIH HHS
  • NIGMS NIH HHS
  • Dr. Miriam and Sheldon G. Adelson Medical Research Foundation
  • National Cancer Institute
  • National Institute of General Medical Sciences

Zitieren

APA

Wilson, H. P., Stefanski, C. D., Caksa, S., Mersky, G. L., Varney, S. D., Haj, J. I., Erkes, D. A., Purwin, T. J., Chua, V., & Aplin, A. E. (2026). Diacylglycerol Kinase Eta as a Novel Target in NRAS Mutant Melanoma. Pigment Cell & Melanoma Research, 39(3). https://doi.org/10.1111/pcmr.70090

Vancouver

Wilson HP, Stefanski CD, Caksa S, Mersky GL, Varney SD, Haj JI, et al. Diacylglycerol Kinase Eta as a Novel Target in NRAS Mutant Melanoma. Pigment Cell & Melanoma Research. 2026;39(3). doi:10.1111/pcmr.70090

BibTeX
@article{Wilson2026,
  author = {Wilson, Haley P and Stefanski, Casey D and Caksa, Signe and Mersky, Glenn L and Varney, Scott D and Haj, Jelan I and Erkes, Dan A and Purwin, Timothy J and Chua, Vivian and Aplin, Andrew E},
  title = {Diacylglycerol Kinase Eta as a Novel Target in NRAS Mutant Melanoma},
  journal = {Pigment Cell & Melanoma Research},
  year = {2026},
  volume = {39},
  number = {3},
  doi = {10.1111/pcmr.70090}
}
Kostenlos starten →